AMP-activated protein kinase as a target for preconditioning in transplantation medicine

Transplantation

Volumn 90, Issue 11, 2010, Pages 1241-

  Padrissa Altés, Susagna ^a   Zaoualí, Mohamed Amine ^a,b   Roselló Catafau, Joan ^a,b,c  

^a INST D INVESTIGACIONS B   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENYLATE KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PRESERVATION SOLUTION; PROTEIN KINASE B; SOMATOMEDIN BINDING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ENZYME ACTIVATION; GRAFT PRESERVATION; LETTER; LIVER GRAFT; LIVER ISCHEMIA; LIVER PRESERVATION; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSPLANTATION;

AMP-ACTIVATED PROTEIN KINASES; ENZYME ACTIVATION; HUMANS; LIVER; LIVER TRANSPLANTATION; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 78650335122     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f9963e     Document Type: Letter

References (10)

1. Bouma HR, Ketelaar ME, Yard BA, et al. AMP-activated protein kinase as a target for preconditioning in transplantation medicine. Transplantation 2010; 90: 353.
2. Lochner A, Marais E, Du Toit E, et al. Nitric oxide triggers classic ischemic preconditioning. Ann N Y Acad Sci 2002; 962: 402.
3. Peralta C, Bartrons R, Serafin A, et al. Adeno-sine monophosphate- activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 2001; 34: 1164.
4. Sola A, De Oca J, Gonzalez R, et al. Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation. Ann Surg 2001; 234: 98.
5. Ben Mosbah I, Massip-Salcedo M, Fernandez-Monteiro I, et al. Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: A way of protecting rat steatotic livers. Liver Transpl 2007; 13: 410.
6. Carrasco-Chaumel E, Rosello-Catafau J, Bar-trons R, et al. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol 2005; 43: 997.
7. Zaouali MA, Mosbah IB, Abdennebi HB, et al. New insights into fatty liver preservation using Institute Georges Lopez preservation solution. Transplant Proc 2010; 42: 159.
8. Ben Mosbah I, Rosello-Catafau J, Franco-Gou R, et al. Preservation of steatotic livers in IGL-1 solution. Liver Transpl 2006; 12: 1215.
9. Todo S, Nery J, Yanaga K, et al. Extended preservation of human liver grafts with UW solution. JAMA 1989; 261: 711.
10. Zaouali MA. Insulin-like growth factor- 1 increases fatty liver preservation in IGL-1 solution. World J Gastroenterol (in press).